Article
The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma (NPC) Differs by Somatostatin Receptor 2 (SSTR2) Expression.
Cancer medicine - 1 Sept 2026
Bracken-Clarke Dara, Xue Elisabetta, Krause Harris, Adeyelu Tolulope, Evans Mark G, Akbulut Dilara, Quezado Martha, Gandhi Nishant, Farrell Alex, Soares Heloisa P, Lou Emil, Phan Minh, Patel Rusha, Vanderwalde Ari M, Elliott Andrew, Steuer Conor E, Saba Nabil F, Lubin Daniel J, London Nyall R, Gulley James L, Floudas Charalampos S
Abstract excerpt
Somatostatin receptor 2 is expressed in nasopharyngeal carcinoma (NPC). We report genomic and transcriptomic analysis results of 163 NPC cases, demonstrating that somatostatin receptor 2 (SSTR2) gene expression in EBV-positive and in EBV-negative NPC correlated with genomic alterations and an inflamed microenvironment. Median SSTR2 expression was 6.52 transcripts per million (TPM), ranging from 0.59 TPM (Quartile...
Read the complete abstract on PubMedTopics
- Humans
- Receptors, Somatostatin
- Female
- Nasopharyngeal Carcinoma
